Literature DB >> 17138857

Further evidence that the UGT1A1*28 allele is not associated with coronary heart disease: The ECTIM Study.

Vincent Gajdos, François M Petit, Claire Perret, Alix Mollet-Boudjemline, Patrice Colin, Liliane Capel, Viviane Nicaud, Alun Evans, Dominique Arveiler, Frédéric Parisot, Jeanne Francoual, Emmanuelle Genin, François Cambien, Philippe Labrune.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17138857     DOI： 10.1373/clinchem.2006.078667

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  8 in total

1.  Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Dhandapani Kayathiri; Subramanian Rajan; Deepak Gopal Shewade; Steven Aibor Dkhar; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Kukreti Ritushree; Chandrasekaran Adithan
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

2.  Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

Authors:  Arno Lingenhel; Barbara Kollerits; Johannes P Schwaiger; Steven C Hunt; Richard Gress; Paul N Hopkins; Veit Schoenborn; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

3.  Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.

Authors:  Ying-Hwa Chen; Szu-Chun Hung; Der-Cherng Tarng
Journal:  Clin J Am Soc Nephrol       Date:  2011-03       Impact factor: 8.237

4.  Genetic influences on serum bilirubin in American Indians: The Strong Heart Family Study.

Authors:  Phillip E Melton; Karin Haack; Harald H Göring; Sandy Laston; Jason G Umans; Elisa T Lee; Richard R Fabsitz; Richard B Devereux; Lyle G Best; Jean W Maccluer; Laura Almasy; Shelley A Cole
Journal:  Am J Hum Biol       Date:  2011 Jan-Feb       Impact factor: 1.937

5.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

6.  Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study.

Authors:  Jing-Ping Lin; Johannes P Schwaiger; L Adrienne Cupples; Christopher J O'Donnell; Gang Zheng; Veit Schoenborn; Steven C Hunt; Jungnam Joo; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2009-03-19       Impact factor: 5.162

7.  Bilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression.

Authors:  Dongdong Wang; Anela Tosevska; Elke H Heiß; Angela Ladurner; Christine Mölzer; Marlies Wallner; Andrew Bulmer; Karl-Heinz Wagner; Verena M Dirsch; Atanas G Atanasov
Journal:  J Am Heart Assoc       Date:  2017-04-28       Impact factor: 5.501

8.  The Nonlinear Relationship Between Total Bilirubin and Coronary Heart Disease: A Dose-Response Meta-Analysis.

Authors:  Chaoxiu Li; Wenying Wu; Yumeng Song; Shuang Xu; Xiaomei Wu
Journal:  Front Cardiovasc Med       Date:  2022-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.